Allergan Plc Stock Fundamentals
Allergan Plc fundamentals help investors to digest information that contributes to Allergan Plc's financial success or failures. It also enables traders to predict the movement of Allergan Stock. The fundamental analysis module provides a way to measure Allergan Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allergan Plc stock.
Allergan |
Allergan Plc Company Current Valuation Analysis
Allergan Plc's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Allergan Plc Current Valuation | 81.41 B |
Most of Allergan Plc's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allergan Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Allergan Plc has a Current Valuation of 81.41 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current valuation for all United States stocks is significantly lower than that of the firm.
Allergan Plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Allergan Plc's current stock value. Our valuation model uses many indicators to compare Allergan Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allergan Plc competition to find correlations between indicators driving Allergan Plc's intrinsic value. More Info.Allergan Plc is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Allergan Plc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Allergan Plc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Allergan Plc's earnings, one of the primary drivers of an investment's value.Allergan Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allergan Plc's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allergan Plc could also be used in its relative valuation, which is a method of valuing Allergan Plc by comparing valuation metrics of similar companies.Allergan Plc is currently under evaluation in current valuation category among related companies.
Allergan Fundamentals
| Return On Equity | -0.0913 | |||
| Return On Asset | -0.0564 | |||
| Profit Margin | (0) % | |||
| Operating Margin | 6.84 % | |||
| Current Valuation | 81.41 B | |||
| Shares Outstanding | 328.1 M | |||
| Shares Owned By Insiders | 0.16 % | |||
| Shares Owned By Institutions | 98.25 % | |||
| Number Of Shares Shorted | 15.01 M | |||
| Price To Earning | 24.00 X | |||
| Price To Book | 1.07 X | |||
| Price To Sales | 3.95 X | |||
| Revenue | 15.82 B | |||
| Gross Profit | 13.65 B | |||
| EBITDA | 7.11 B | |||
| Net Income | (9.25 B) | |||
| Cash And Equivalents | 4.56 B | |||
| Cash Per Share | 13.88 X | |||
| Total Debt | 23.08 B | |||
| Debt To Equity | 39.40 % | |||
| Current Ratio | 1.00 X | |||
| Book Value Per Share | 161.90 X | |||
| Cash Flow From Operations | 6.47 B | |||
| Short Ratio | 3.22 X | |||
| Earnings Per Share | (27.98) X | |||
| Price To Earnings To Growth | 3.66 X | |||
| Number Of Employees | 17.4 K | |||
| Beta | 1.2 | |||
| Market Capitalization | 63.66 B | |||
| Total Asset | 135.58 B | |||
| Retained Earnings | 1.02 B | |||
| Working Capital | 287.1 M | |||
| Current Asset | 8.58 B | |||
| Current Liabilities | 8.29 B | |||
| Z Score | 1.2 | |||
| Last Dividend Paid | 0.74 |
Pair Trading with Allergan Plc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allergan Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allergan Plc will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Noble Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Noble Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Noble Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Noble plc to buy it.
The correlation of Noble Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Noble Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Noble plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Noble Plc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Allergan Plc information on this page should be used as a complementary analysis to other Allergan Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Allergan Stock
If you are still planning to invest in Allergan Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allergan Plc's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |